Prolong Pharmaceuticals Announces Completion of Enrollment in Phase II Study of SANGUINATE® in the Treatment of Sickle Cell Disease Patients with Vaso-Occlusive Crisis in an Ambulatory Setting by Prolong Pharma | Dec 1, 2017 | News
Pegylated bovine carboxyhaemoglobin utilisation in a thrombotic thrombocytopenic purpura patient by Prolong Pharma | Aug 1, 2017 | Publications
Summary of the Interagency Oxygen Carrier State of the Science Meeting by Prolong Pharma | Jun 18, 2017 | Conferences